Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. (Q53112545)

11 May 2018

title

Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. (English)

1 reference

11 May 2018

1 reference

2

1 reference

11 May 2018

author name string

Madhavi Tripathi

1

1 reference

11 May 2018

Shichun Peng

3

1 reference

11 May 2018

Suman Kushwaha

4

1 reference

11 May 2018

Amit Batla

5

1 reference

11 May 2018

Abhinav Jaimini

6

1 reference

11 May 2018

Maria M D'Souza

7

1 reference

11 May 2018

Rajnish Sharma

8

1 reference

11 May 2018

Sanjiv Saw

9

1 reference

11 May 2018

Anupam Mondal

10

1 reference

11 May 2018

publication date

13 January 2013

1 reference

11 May 2018

published in

Neuroradiology

1 reference

11 May 2018

volume

55

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

483-492

1 reference

11 May 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Cerebral metabolic changes in early multiple system atrophy: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

FDG PET in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Deep brain stimulation for the treatment of atypical parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00234-012-1132-7

18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes

21 January 2018

1 reference

12 December 2020

Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions

1 reference

12 December 2020

The metabolic topography of parkinsonism

1 reference

12 December 2020

Reproducibility of regional metabolic covariance patterns: comparison of four populations.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00234-012-1132-7

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018